TINLEY CHEN: Open Payments
NPI 1902490220 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,998 in 144 payments from 19 companies in 2025. Trend: 2023 $3,385 · 2024 $2,612 · 2025 $3,998
Food & beverage: $3,899Education: $99
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 23 | $901 |
| Incyte Corporation | 17 | $603 |
| Janssen Biotech, Inc. | 16 | $558 |
| GENZYME CORPORATION | 8 | $279 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 16 | $273 |
| ABBVIE INC. | 12 | $223 |
| Galderma Laboratories, L.P. | 10 | $168 |
| Novartis Pharmaceuticals Corporation | 6 | $161 |
| LEO Pharma Inc. | 7 | $143 |
| Arcutis Biotherapeutics, Inc. | 5 | $135 |
Products named: Bimzelx, TREMFYA, OPZELURA, DUPIXENT, RINVOQ, NEMLUVIO, Winlevi, Zoryve.
Industry payments across NY — which companies pay providers there.
